Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists

被引:40
作者
Bonnefous, C
Vernier, JM
Hutchinson, JH
Chung, J
Reyes-Manalo, G
Kamenecka, T
机构
[1] Merck Res Labs, Dept Med Chem, San Diego, CA 92121 USA
[2] Merck Res Labs, Dept Neuropharmacol, San Diego, CA 92121 USA
关键词
mGluR5; amides; CNS disorders;
D O I
10.1016/j.bmcl.2004.11.078
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The mGlu5 receptor has been implicated in a number of CNS disorders. Herein, we report on the discovery, synthesis, and biological evaluation of dipyridyl amides as small molecules mGluR5 antagonists. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1197 / 1200
页数:4
相关论文
共 19 条
[11]   Glutamate receptors in the mammalian central nervous system [J].
Ozawa, S ;
Kamiya, H ;
Tsuzuki, K .
PROGRESS IN NEUROBIOLOGY, 1998, 54 (05) :581-618
[12]   The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology [J].
Pin, Jean-Philippe ;
Acher, Francine .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) :297-317
[13]   The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats [J].
Schulz, B ;
Fendt, M ;
Gasparini, F ;
Lingenhöhl, K ;
Kuhn, R ;
Koch, M .
NEUROPHARMACOLOGY, 2001, 41 (01) :1-7
[14]   Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608) [J].
Spooren, WPJM ;
Schoeffter, P ;
Gasparini, F ;
Kuhn, R ;
Gentsch, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 435 (2-3) :161-170
[15]  
Spooren WPJM, 2000, J PHARMACOL EXP THER, V295, P1267
[16]   Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist [J].
Tatarczynska, E ;
Klodzinska, A ;
Chojnacka-Wójcik, E ;
Palucha, A ;
Gasparini, F ;
Kuhn, R ;
Pilc, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (07) :1423-1430
[17]   Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel Analgesics [J].
Varney, M. A. ;
Gereau, R. W. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) :283-296
[18]  
Varney MA, 1999, J PHARMACOL EXP THER, V290, P170
[19]  
Varney MA, 2000, DRUG DISCOV TODAY, P20